Vericel (VCEL) Capital Expenditures (2010 - 2026)
Vericel's (VCEL) quarterly Capital Expenditures came in at $1.5 million in Q1 2026, down 89.72% year-on-year from $14.2 million in Q1 2025, and down 33.2% quarter-over-quarter from $2.2 million in Q4 2025.
Vericel (VCEL) Capital Expenditures (2010 - 2026) Analysis & Trends
Vericel has disclosed Capital Expenditures across 16 years of filings, most recently posting $1.5 million for Q1 2026.
- Capital Expenditures for Q1 2026 came in at $1.5 million, down 89.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.4 million (down 77.54% YoY), and the FY2025 annual result was $27.2 million, down 57.54% from the prior year.
- Capital Expenditures came in at $1.5 million for Q1 2026 at Vericel, down from $2.2 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $37.0 million in Q3 2024 to a low of -$12.8 million in Q2 2025.
- The 5-year median for Capital Expenditures is $3.1 million (2022), against an average of $7.1 million.
- Peak annual rise in Capital Expenditures reached 1127.89% in 2022, while the deepest fall reached 2312.0% in 2022.
- Vericel's Capital Expenditures stood at $1.1 million in 2022, then jumped by 596.44% to $7.8 million in 2023, then soared by 75.97% to $13.8 million in 2024, then tumbled by 84.14% to $2.2 million in 2025, then plunged by 33.2% to $1.5 million in 2026.
- The last three Capital Expenditures figures came in at $1.5 million (Q1 2026), $2.2 million (Q4 2025), and $23.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | 23.54 Mn |
| Sep 30, 2025 | 23.54 Mn |
| Jun 30, 2025 | -12.77 Mn |
| Jun 30, 2025 | -12.77 Mn |
| Mar 31, 2025 | 14.21 Mn |
| Mar 31, 2025 | 14.21 Mn |
| Dec 31, 2024 | 13.79 Mn |
| Dec 31, 2024 | 13.79 Mn |
| Sep 30, 2024 | 36.97 Mn |
| Sep 30, 2024 | 36.97 Mn |
| Jun 30, 2024 | -804,000.00 |
| Jun 30, 2024 | -804,000.00 |
| Mar 31, 2024 | 14.02 Mn |
| Mar 31, 2024 | 14.02 Mn |
| Dec 31, 2023 | 7.84 Mn |
| Dec 31, 2023 | 7.84 Mn |